ÂÜÀòÂÒÂ×

Adam Krisko Nygaard currently serves as a Board Member at Zealand Pharma since March 2023. Previously, Adam held the position of Senior Statistical Programmer at Y-mAbs Therapeutics, Inc. from November 2021 to February 2023, where responsibilities included statistical programming for regulatory submissions and participation in clinical study report production. Adam's experience also includes a role as a Statistical Programmer at LEO Pharma from January 2018 to October 2021, focusing on statistical analyses and the creation of CDISC compliant datasets. Additional roles include Data Analyst and Business Analyst at various companies, emphasizing data analytics and financial analysis. Adam's academic credentials include a Graduate Certificate in Epidemiology and Clinical Research from Stanford University School of Medicine and multiple degrees from Roskilde University and other institutions.